

Classification: Melanocortin Receptor Agonist
Active substance: Bremelanotide
Manufacturer: Peptide Hubs
Form/Strength: Lyophilized Powder / 10 mg per vial
Pack size: 2 mL Vial
Route: Subcutaneous Injection
Lab Test: View Result
For bodybuilders, fitness enthusiasts, and anyone seeking to overcome sexual dysfunction or simply enhance their intimate experiences, Peptide Hubs PT-141 represents a revolutionary approach to sexual health and performance. This potent 10mg vial contains Bremelanotide—a synthetic melanocortin receptor agonist that directly activates the neural pathways responsible for sexual arousal in both men and women. Unlike traditional solutions that work on vascular mechanisms, PT-141 operates through the central nervous system to create powerful, natural-feeling desire and arousal. Our commitment to quality is verified by independent lab testing, confirming each vial contains an impressive 11.78mg with exceptional 99.831% purity.
PT-141 is a synthetic heptapeptide (7-amino acid chain) analog of α-MSH (alpha-melanocyte-stimulating hormone) that functions as a potent melanocortin receptor agonist. It was originally developed from Melanotan II while researchers were investigating sunless tanning agents, but was found to have powerful pro-sexual effects without the tanning properties. Unlike PDE5 inhibitors like Viagra or Cialis that work by increasing blood flow, Bremelanotide PT-141 (Peptide Hubs) works centrally in the brain by activating MC4R and MC1R receptors in the hypothalamus—the command center for sexual arousal. This unique mechanism of action has been documented in research available through the NCBI PubMed Central database.
PT-141 operates through a sophisticated neurological mechanism that makes it uniquely effective for sexual enhancement:
When you buy PT-141 online from Peptide Hubs, you're investing in a product that delivers comprehensive intimate enhancement:
Proper dosing is essential for achieving optimal results while minimizing potential side effects. PT-141 is typically administered via subcutaneous injection as needed:
The vial must be reconstituted with bacteriostatic water before use. For a 10mg (10,000mcg) vial, adding 2ml of BAC water creates a concentration of 5,000mcg/ml, making dose measurement with an insulin syringe precise.
PT-141 is typically used on an as-needed basis rather than in traditional cycles. However, for those with persistent sexual health concerns, a structured approach can be beneficial. For comprehensive enhancement, PT-141 stacks well with other products that address different aspects of sexual health and performance:
While generally well-tolerated, PT-141 can produce some side effects, particularly at higher doses:
These side effects are generally dose-dependent and diminish with repeated use. Taking PT-141 on an empty stomach can reduce nausea. Contraindications include uncontrolled hypertension, cardiovascular disease, and pregnancy.
To achieve optimal results from your PT-141 investment, implement these evidence-based strategies:
Date: 2025-04-22
Result: 11.78 mg; Purity: 99.831%
PT-141 typically begins working within 2-4 hours after administration, with peak effects occurring around 4-6 hours post-injection. The effects can last anywhere from 8-16 hours, depending on the individual's metabolism and dosage. Unlike fast-acting PDE5 inhibitors, PT-141 works through neurological pathways that require more time to activate but provide longer-lasting results. The extended duration allows for spontaneous intimacy throughout the day or evening without precise timing concerns.
Yes, PT-141 is highly effective for women and was actually FDA-approved specifically for hypoactive sexual desire disorder (HSDD) in premenopausal women under the brand name Vyleesi. It works equally well in both genders by targeting fundamental neurological arousal pathways. Women typically experience increased sexual thoughts, desire, and arousal similar to men. The dosing protocol is generally the same, though women may find lower doses (1-1.5mg) effective. It's particularly beneficial for women experiencing low libido due to SSRI medications or hormonal changes.
The primary difference is their mechanism of action. PDE5 inhibitors like Viagra and Cialis work primarily on vascular function by increasing blood flow to genital tissues. PT-141 works centrally in the brain by activating melanocortin receptors to create genuine sexual desire and arousal. PT-141 addresses the mental aspect of sexual function (libido), while traditional ED medications address the physical aspect (blood flow). Many users find combining both types of medications provides comprehensive enhancement—PT-141 for desire and PDE5 inhibitors for performance.
Several strategies can help reduce PT-141-related nausea: 1) Start with a low dose (0.5mg) and gradually increase, 2) Always administer on an empty stomach, 3) Stay well-hydrated before and after injection, 4) Consider taking an over-the-counter anti-nausea medication 30 minutes before PT-141, 5) Lie down for 30-60 minutes after injection if nausea occurs, 6) The nausea typically diminishes with repeated use as your body adapts. Most users find the side effect manageable when balanced against the significant benefits.
PT-141 is generally safe with most medications due to its unique neurological mechanism. It can be safely combined with PDE5 inhibitors (Viagra, Cialis) as they work through different pathways. However, caution should be exercised with medications that affect blood pressure or heart rate. It's not recommended to combine with other melanocortin agonists. Always consult with a healthcare provider if taking antidepressants, blood pressure medications, or other serious prescriptions. PT-141 does not interact with alcohol, but excessive consumption may diminish its effects.
Please log in to write PT-141 10 mg review.
Classification: Growth Hormone Secretagogue (GHRP)
Active substance: Ipamorelin
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder, 5 mg/vial
Pack size: 2 mL Vial
Route: Subcutaneous (SC) Injection
Lab Test: View Result
Classification: Synthetic Melanocortin Peptide
Active substance: Melanotan II
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder / 10 mg per vial
Pack size: 2 mL Vial
Route: Subcutaneous Injection (Reconstituted with Bacteriostatic Water)
Lab Test: View Result
Classification: Metabolic Peptide (GLP-1/GIP Receptor Agonist)
Active substance: Tirzepatide
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder, 5 mg/vial
Pack size: 2 mL Vial
Route: Subcutaneous Injection (Reconstitution Required)
Lab Test: View Result
Classification: Nootropic Peptide
Active substance: Semax
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder / 5 mg per 2 mL vial
Pack size: 1 Vial
Route: Intranasal or Subcutaneous
Lab Test: View Result
Classification: Research Peptide (Body Protecting Compound)
Active substance: BPC 157 (Pentadecapeptide)
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder, 5 mg/vial
Pack size: 2 mL Vial (Requires Reconstitution)
Route: Subcutaneous (SubQ) or Near Injury
Lab Test: View Result